Effects of Low-Intensity Blood Flow Restriction Training in Normoxia and Hypoxia Conditions

June 10, 2024 updated by: Michal Krzysztofik, The Jerzy Kukuczka Academy of Physical Education in Katowice

Acute and Chronic Effects of Low-Intensity Blood Flow Restriction Training in Normoxia and Hypoxia Conditions on Muscle Strength, Thickness, Catecholamine, and Inflammatory Responses in Physically Active Adults

One approach to significantly reducing resistance training intensity while maintaining effectiveness in muscle mass and strength development involves conducting training sessions under hypoxic conditions. This is likely due to heightened physiological responses. While sports science research indicates a substantial impact of hypoxic conditions on immediate increases in metabolic stress and augmented hormonal responses, recent findings suggest that the role of their influence on skeletal muscle adaptations post-resistance training under hypoxic conditions remains unknown. Additionally, there is a lack of reports on whether the type of hypoxia applied via blood flow restriction or chamber differentiates the increase in secretion of these catecholamines in both immediate and long-term aspects.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Śląsk
      • Katowice, Śląsk, Poland, 40-065
        • The Jerzy Kukuczka Academy of Physical Education

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Regularly physically active (at least 30 mins of structured exercise 3 times per week),
  • Sea-level natives,
  • Experienced in resistance training (at least one year of experience in regular resistance exercise)

Exclusion Criteria:

  • presence of any medical risk factors to exercise and/or exposure to altitude
  • presence of any medical condition that would make the protocol unreasonably hazardous for the participant
  • smokers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Low-Intensity Normoxia
Participants will be breathing room air, and perform low-intensity lower-body resistance exercise.
4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in normoxic conditions performed twice a week for 6 weeks.
Active Comparator: High-Intensity Normoxia
Participants will be breathing room air, and perform high-intensity lower-body resistance exercise.
4 sets of 10 repetitions of leg press exercise at 70-80% one-repetition maximum (weeks 1-3: 70%, weeks 4-6: 80%) in normoxic conditions performed twice a week for 6 weeks.
Experimental: Low-Intensity Normoxia with Blood Flow Restriction
Participants will be breathing room air, and perform low-intensity lower-body resistance exercise combined with blood flow restriction.
4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in normoxic conditions with lower-limbs blood flow restriction (80% total occlusion pressure) performed twice a week for 6 weeks.
Experimental: Low-Intensity Hypoxia
Participants will be breathing a 13% oxygen gas mixture, and perform low-intensity lower-body resistance exercise.
4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in hypoxia conditions (3500 meters above sea) performed twice a week for 6 weeks.
Experimental: Low-Intensity Hypoxia with Blood Flow Restriction
Participants will be breathing a 13% oxygen gas mixture, and perform low-intensity lower-body resistance exercise combined with blood flow restriction.
4 sets of 30/15/15/15 repetitions of leg press exercise with a load of 20-30% of one-repetition maximum (weeks 1-3: 20%, weeks 4-6: 30%) in normobaric hypoxia conditions (3500 meters above sea) with lower-limbs blood flow restriction (80% total occlusion pressure) performed twice a week for 6 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Force Output
Time Frame: Immediately pre and post first and last training session
Force plate will be used to quantify maximum absolute (N) and relative force output (body mass divided per force output in N/kg) during maximum voluntary isometric back squat in a 100ms time frame. Participants will be pushing as hard and as fast as they can on an unmoveable barbell while standing on a force plate.
Immediately pre and post first and last training session
One-Repetition Maximum
Time Frame: within 5 days from the start and end of training
One-Repetition Maximum test in leg press exercise will be performed to quantify maximum lower body dynamic strength (kg). Participants will be performing single repetitions of leg press exercise with increasing load until volitional failure.
within 5 days from the start and end of training
Maximum Number of Repetitions
Time Frame: within 5 days from the start and end of training
A maximum number of repetitions in leg press exercise will be performed to quantify lower body strength endurance (number). Participants will be performing leg press exercise at 50% of one-repetition maximum until volitional failure.
within 5 days from the start and end of training
Countermovement Jump Height
Time Frame: Immediately pre and post first and last training session
Countermovement jump height will be performed estimated via take-off velocity performed on force plates to Participants will perform 3 trials on force plate.
Immediately pre and post first and last training session
Countermovement Jump Power Output
Time Frame: Immediately pre and post first and last training session
Countermovement jump performance will be performed to quantify maximum lower body relative and absolute power-output (W/kg and W), and jump height (cm) with concomitant assessment of contraction depth (cm) and contraction time (ms). Participants will perform 3 trials on force plate.
Immediately pre and post first and last training session
Catecholamine Response
Time Frame: Immediately pre and post first and last training session
A blood sample will be analyzed to quantify changes in epinephrine and norepinephrine level changes.
Immediately pre and post first and last training session
Muscle Stiffness
Time Frame: Immediately pre and post first and last training session
Myotonometry measure will be used to quantify changes in vastus medialis oblique muscle stiffness in N/m
Immediately pre and post first and last training session
Muscle Thickness
Time Frame: within 5 days from the start and end of training
Ultrasonography measure will be used to quantify changes in vastus medialis oblique cross-sectional area.
within 5 days from the start and end of training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perception of Effort
Time Frame: Immediately pre and post every training session
The rate of perceived exertion scale will be used to quantify the perception of effort (units on a scale).
Immediately pre and post every training session
Blood Pressure
Time Frame: Immediately pre and post first and last training session
Systolic and diastolic blood pressure will be measured to quantify blood pressure responses.
Immediately pre and post first and last training session
Perception of Pain
Time Frame: Immediately pre and post every training session
A visual analogue scale will be used to quantify the perception of pain (units on a scale).
Immediately pre and post every training session

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Body Mass
Time Frame: within 5 days from the start and end of training
Dual-energy X-ray absorptiometry will be used to quantify total body mass (kg).
within 5 days from the start and end of training
Percentage Body Fat
Time Frame: within 5 days from the start and end of training
Dual-energy X-ray absorptiometry will be used to quantify the percentage of body fat (%).
within 5 days from the start and end of training
Bone Mass Density
Time Frame: within 5 days from the start and end of training
Dual-energy X-ray absorptiometry will be used to quantify femur bone mass density (g/cm2).
within 5 days from the start and end of training
Bone Mineral Content
Time Frame: within 5 days from the start and end of training
Dual-energy X-ray absorptiometry will be used to quantify bone mineral content (g).
within 5 days from the start and end of training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2023

Primary Completion (Estimated)

June 20, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

November 25, 2023

First Submitted That Met QC Criteria

December 6, 2023

First Posted (Actual)

December 15, 2023

Study Record Updates

Last Update Posted (Actual)

June 11, 2024

Last Update Submitted That Met QC Criteria

June 10, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SKN/SP/569582/2023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resistance Training

Clinical Trials on low-intensity resistance training

Subscribe